- The Company is offering to purchase up to 33,500,000 Ordinary Shares (including Ordinary Shares represented by ADSs) representing approximately 12 percent of the Company's issued ordinary share capital as at 16 May 2024 (being the latest practicable date before publication of this announcement ("Latest Practicable Date")) at a fixed price of 250 pence per Ordinary Share (equivalent to £25.00 per ADS) (the "Tender Price") up to a maximum aggregate amount of $100 million. The maximum amount of $100 million will be translated into a pounds sterling amount on the Ordinary Share Closing Date, and that pounds sterling amount shall determine the maximum number of shares to be accepted for payment in the Tender Offer.
- The Tender Price represents a premium of 25 percent to PureTech's trailing volume weighted average price per Ordinary Share over the three days prior to 19 March 2024, the date of the Company's initial announcement of the Tender Offer proposals and a premium of 12.6 percent to the closing price of 222 pence per Ordinary Share on the Latest Practicable Date.
PureTech Health Announces Launch of $100M Tender Offer At Premium Price of 250 Pence Per Share
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.